Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ginsberg

Showing results (21-30 of 369) with videos related to

Pageof 37
Sort By:
Annals of Internal Medicine|June 1, 1997
Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answerH N Ginsberg
The American Journal of Cardiology|April 4, 1998
Effects of statins on triglyceride metabolismH N Ginsberg
Metabolism: Clinical and Experimental|October 1, 1977
Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapyH N Ginsberg
The American Journal of Cardiology|May 18, 2001
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapyH N Ginsberg
Diabetes Care|September 1, 1991
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesisH N Ginsberg
Clinical and Experimental Pharmacology & Physiology|May 1, 1997
Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cellsH N Ginsberg
The American Journal of Psychiatry|July 1, 1986
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawalH N Ginsberg
Cell Metabolism|September 5, 2006
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?Henry N Ginsberg
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Niacin in the metabolic syndrome: more risk than benefit?Henry N Ginsberg
The Journal of Clinical Investigation|July 1, 1993
Syndrome X: what's old, what's new, what's etiologic?H N Ginsberg
Pageof 37

Showing results (21-30 of 369) with videos related to

Sort By:
Pageof 37
Annals of Internal Medicine|June 1, 1997
Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answerH N Ginsberg
The American Journal of Cardiology|April 4, 1998
Effects of statins on triglyceride metabolismH N Ginsberg
Metabolism: Clinical and Experimental|October 1, 1977
Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapyH N Ginsberg
The American Journal of Cardiology|May 18, 2001
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapyH N Ginsberg
Diabetes Care|September 1, 1991
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesisH N Ginsberg
Clinical and Experimental Pharmacology & Physiology|May 1, 1997
Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cellsH N Ginsberg
The American Journal of Psychiatry|July 1, 1986
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawalH N Ginsberg
Cell Metabolism|September 5, 2006
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?Henry N Ginsberg
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Niacin in the metabolic syndrome: more risk than benefit?Henry N Ginsberg
The Journal of Clinical Investigation|July 1, 1993
Syndrome X: what's old, what's new, what's etiologic?H N Ginsberg
Pageof 37